MARKET

STAB

STAB

Statera Biopharma Inc
EXMKT
0.0001
0.0000
0.00%
Closed 13:05 12/20 EST
OPEN
0.0001
PREV CLOSE
0.0001
HIGH
0.0001
LOW
0.0001
VOLUME
5.64K
TURNOVER
1
52 WEEK HIGH
0.0007
52 WEEK LOW
0.0001
MARKET CAP
7.14K
P/E (TTM)
-0.0001
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at STAB last week (1209-1213)?
Weekly Report · 5d ago
Weekly Report: what happened at STAB last week (1202-1206)?
Weekly Report · 12/09 10:32
Weekly Report: what happened at STAB last week (1125-1129)?
Weekly Report · 12/02 10:32
Weekly Report: what happened at STAB last week (1118-1122)?
Weekly Report · 11/25 10:27
Weekly Report: what happened at STAB last week (1111-1115)?
Weekly Report · 11/18 10:25
Weekly Report: what happened at STAB last week (1104-1108)?
Weekly Report · 11/11 10:33
Weekly Report: what happened at STAB last week (1028-1101)?
Weekly Report · 11/04 10:32
Weekly Report: what happened at STAB last week (1021-1025)?
Weekly Report · 10/28 10:26
More
About STAB
Statera BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on developing immunotherapies autoimmune, neutropenia/anemia, emerging viruses and cancers based on a platform designed to rebalance the body’s immune system and restore homeostasis. Through its developmental Advanced Immunomodulating Multi-Component System (AIMS) platform, it has advanced several late-stage developmental product candidates that include the STAT-200 and STAT-600 AIMS programs that are evaluating noroxymorphone and proenkephalin analogs for the treatment of certain cancer, inflammatory, autoimmune, and emerging viruses. Its STAT-201is focused on the restoration of mucosal healing and intestinal barrier function as an adjunct to the standard of care in moderate to severe Crohn’s Disease. Its STAT-205 is to potentially treat acute and post-acute COVID infections by modulating immune system function and by decreasing elevated inflammatory responses associated with SARS-CoV-2 viral infections.

Webull offers Statera Biopharma Inc stock information, including EXMKT: STAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STAB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STAB stock methods without spending real money on the virtual paper trading platform.